HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seong-Gyu Ko Selected Research

juzentaihoto

4/2019The efficacy and safety of Sipjeondaebo-tang in Korean patients with cold hypersensitivity in the hands and feet: a protocol for a pilot, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
1/2018Sipjeondaebo-tang in patients with breast cancer with fatigue: a protocol for a pilot, randomised, double-blind, placebo-controlled, cross-over trial.
1/2018Corrigendum to "Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial".
1/2017Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial.
12/2016Sipjeondaebo-tang in patients with cancer with anorexia: a protocol for a pilot, randomised, controlled trial.
1/2014Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seong-Gyu Ko Research Topics

Disease

63Neoplasms (Cancer)
06/2022 - 03/2005
23Breast Neoplasms (Breast Cancer)
11/2021 - 02/2009
13Inflammation (Inflammations)
09/2021 - 03/2009
9Stomach Neoplasms (Stomach Cancer)
09/2021 - 07/2006
8Atopic Dermatitis (Atopic Eczema)
04/2021 - 01/2012
7Anorexia
02/2022 - 01/2014
7Allergic Rhinitis
11/2021 - 01/2014
6Lung Neoplasms (Lung Cancer)
03/2022 - 11/2008
6Obesity
07/2020 - 04/2012
5Body Weight (Weight, Body)
02/2022 - 04/2012
4Hyperalgesia
06/2022 - 01/2021
4Diarrhea
02/2022 - 03/2009
4Prostatic Neoplasms (Prostate Cancer)
01/2022 - 12/2016
4Ovarian Neoplasms (Ovarian Cancer)
11/2021 - 04/2016
4Edema (Dropsy)
09/2021 - 01/2010
4Weight Loss (Weight Reduction)
06/2020 - 01/2016
3Neoplasm Metastasis (Metastasis)
03/2022 - 01/2013
3Neuralgia (Stump Neuralgia)
01/2022 - 01/2021
3Hypersensitivity (Allergy)
11/2021 - 01/2010
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 01/2020
3Cardiovascular Diseases (Cardiovascular Disease)
11/2020 - 03/2008
3Cold Hypersensitivity
04/2019 - 01/2017
3Necrosis
11/2018 - 05/2014
3Cachexia
01/2017 - 01/2014
3Gastritis
01/2014 - 07/2008
3Carcinoma (Carcinomatosis)
08/2005 - 05/2004
2Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 01/2018
2Hypoxia (Hypoxemia)
03/2022 - 01/2020
2Triple Negative Breast Neoplasms
01/2022 - 11/2016
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 09/2021
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2021
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2021 - 01/2021
2Demyelinating Diseases (Demyelinating Disease)
10/2021 - 01/2021
2Neutropenia
09/2021 - 01/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 01/2020
2Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2020 - 01/2016
2Skin Diseases (Skin Disease)
07/2018 - 01/2012
2Fatigue
01/2018 - 02/2012

Drug/Important Bio-Agent (IBA)

13Pharmaceutical PreparationsIBA
02/2022 - 08/2011
13Plant ExtractsIBA
02/2022 - 01/2013
7Ethanol (Ethyl Alcohol)IBA
12/2016 - 07/2006
6CytokinesIBA
05/2022 - 01/2012
6Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 04/2016
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 06/2014
6Immunoglobulin E (IgE)IBA
11/2021 - 06/2010
6Biological ProductsIBA
11/2020 - 08/2005
6juzentaihotoIBA
04/2019 - 01/2014
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 11/2009
6STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
12/2017 - 01/2013
5Cisplatin (Platino)FDA LinkGeneric
02/2022 - 03/2009
5QuercetinIBA
01/2021 - 11/2008
5DSGOSTIBA
01/2018 - 04/2016
5ApigeninIBA
08/2017 - 07/2012
4cucurbitacin DIBA
01/2022 - 01/2013
4Messenger RNA (mRNA)IBA
01/2022 - 01/2012
4Docetaxel (Taxotere)FDA Link
01/2022 - 09/2020
4Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2015
4LipidsIBA
06/2020 - 04/2012
4Phytoestrogens (Phytoestrogen)IBA
10/2015 - 10/2011
3Oxygen (Dioxygen)IBA
03/2022 - 04/2016
3VimentinIBA
03/2022 - 11/2021
3Transcription Factors (Transcription Factor)IBA
03/2022 - 01/2013
3SaponinsIBA
01/2022 - 03/2005
3Proteins (Proteins, Gene)FDA Link
11/2021 - 02/2009
3AntioxidantsIBA
11/2020 - 01/2010
3FlavonoidsIBA
01/2020 - 07/2016
3Histamine Antagonists (Antihistamines)IBA
03/2017 - 11/2013
3AdiponectinIBA
11/2016 - 01/2013
3CaspasesIBA
07/2016 - 11/2008
3buteinIBA
04/2016 - 06/2014
3OvalbuminIBA
01/2016 - 01/2012
3bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2015 - 02/2011
3Caspase 3 (Caspase-3)IBA
02/2011 - 10/2004
2Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2022 - 08/2021
2AndrogensIBA
01/2022 - 12/2016
2TriterpenesIBA
01/2022 - 11/2020
2Cadherins (E-Cadherin)IBA
11/2021 - 11/2021
2diphenyleneiodoniumIBA
11/2021 - 11/2021
2Indicators and Reagents (Reagents)IBA
11/2021 - 01/2018
2Peptides (Polypeptides)IBA
10/2021 - 11/2016
2Myelin-Oligodendrocyte GlycoproteinIBA
10/2021 - 01/2021
2salicylhydroxamic acid (SHAM)IBA
10/2021 - 01/2021
2Lysophosphatidic Acid ReceptorsIBA
10/2021 - 01/2021
2Therapeutic UsesIBA
09/2021 - 01/2014
2Dinitrochlorobenzene (DNCB)IBA
04/2021 - 01/2012
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2014
2Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 12/2016
2Glycoproteins (Glycoprotein)IBA
06/2019 - 03/2008
2InterleukinsIBA
11/2018 - 04/2012
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 01/2013
2sho-seiryu-toIBA
09/2017 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016 - 04/2016

Therapy/Procedure

19Therapeutics
03/2022 - 07/2006
14Drug Therapy (Chemotherapy)
11/2021 - 09/2010
14Traditional Medicine (Folk Remedies)
10/2021 - 03/2008
8Oral Administration
01/2022 - 03/2008
6East Asian Traditional Medicine (Oriental Medicine)
01/2017 - 08/2007
5Complementary Therapies (Alternative Medicine)
07/2020 - 01/2014
3Radiotherapy
01/2022 - 09/2021
2Moxibustion
06/2018 - 07/2016